Add new comment

I'll put her on ondansetron ampulle German drugmaker Merck KGaA will conduct new testson an experimental lung cancer vaccine which failed a previouslate-stage clinical trial, it said. The drug, licensed from U.S.biotech firm Oncothyreon, will be tested on patients withlocally advanced Stage III non-small cell lung cancer, whichcannot be surgically removed, unchanged from the previous trialcalled START, the firm said.